Talimogene laherparepvec treatment to overcome...

Cancer Immunology, Immunotherapy 2020 / 2

Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients

Fröhlich, Anne, Niebel, Dennis, Fietz, Simon, Egger, Eva, Buchner, Andrea, Sirokay, Judith, Landsberg, Jennifer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-020-02487-x
Date:
February, 2020
File:
PDF, 866 KB
2020
Conversion to is in progress
Conversion to is failed